We urge policymakers, healthcare providers, and employers to support equitable kidney care through:
Chronic kidney disease affects more than 472,000 Australians, with rising rates due to aging, diabetes, and hypertension. First Nations peoples and immigrant populations — including Vietnamese Australians — experience significantly higher rates of kidney failure, hospitalizations, and complications.
Dialysis, while life-extending, takes a toll. Patients often suffer fatigue, infections, mental health struggles, and career limitations. The COVID-19 pandemic only deepened the challenges by reducing access to deceased donor organs.
VietKHA is responding with solutions that are not just clinical — but also emotional, economic, and ethical.
At VietKHA, we don't just arrange transplants — we change lives. Our approach bridges continents and removes barriers, giving patients a second chance at life.
To improve kidney health outcomes for individuals of Vietnamese origin by facilitating timely, ethical, and high-quality access to kidney transplantation through global medical collaboration, patient advocacy, and compassionate care.
VietKHA is a health alliance network founded in 2022 to address the growing burden of chronic kidney disease (CKD) in the Vietnamese community. We work tirelessly to reduce barriers to kidney transplantation and provide access to quality, ethical care.
Our primary focus is supporting both transplant recipients and living or deceased donors throughout their medical journey. We advocate for faster access to transplants, especially for patients experiencing long wait times in Australia’s public health system. Through international collaboration, patient advocacy, and end-to-end coordination, we help restore health and independence to those affected by kidney failure.
Behind every life we help change is a passionate team of medical experts and support staff who care deeply about what they do. With compassion, skill, and a shared mission, our team walks beside each patient and donor—every step of the way.